Shareholders' Equity (Details Narrative) (USD $)	0 Months Ended	12 Months Ended
	Nov. 13, 2013	Dec. 31, 2013	Dec. 31, 2012	May 02, 2013	Aug. 10, 2011	Dec. 31, 2003
Series A convertible preferred stock						386,208
Outstanding Series A covertible preferred stock		5,708	5,708
Dividend yield		6.75%	6.75%
Term of dividend			5 years
Accured balance due on Series A Convertible Preferred Stock		$ 42,047	$ 42,047
Number of common stock sale during period		190,000
Shares issued in private placement to investors		205,000	95,000
Sale price of common stock		$ 0.50
Common stock exercised by director			7,500
Common stock strike price per share			$ 1.05
Total consideration of shares issued			7,875
Number of option issued to purchase number of common stock	50,000
Option exercise price, per share	$ 0.70	$ 1.05
Stock based compensation		16,719
Exercise of stock options				452,500	460,000
Charge to share based compensation		$ 193,997	$ 214,563
Accredited Investor [Member]
Number of common stock sale during period			410,000